Biomarkers and response to bevacizumab--response.

Collinson, Fiona; Hutchinson, Michelle; Craven, Rachel A; Cairns, David A; Alexandre, Zougman; Wind, Tobias C; Gahir, Narinder; Messenger, Michael P; Jackson, Sharon; Thompson, Douglas; Adusei, Cybil; Ledermann, Jonathan; Hall, Geoffrey; Jayson, Gordon C; Selby, Peter J; Banks, Rosamonde E

Collinson, Fiona; Hutchinson, Michelle; Craven, Rachel A; Cairns, David A; Alexandre, Zougman; Wind, Tobias C; Gahir, Narinder; Messenger, Michael P; Jackson, Sharon; Thompson, Douglas; Adusei, Cybil; Ledermann, Jonathan; Hall, Geoffrey; Jayson, Gordon C; Selby, Peter J; Banks, Rosamonde E.

Afiliação

Collinson F; Authors' Affiliations: Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds; St James's Institute of Oncology, Bexley Wing; Cancer Research UK Centre, Leeds Institute of Molecular Medicine, St James's University Hospital; Department of Clinical Biochemistry and Immunology, Leeds General Infirmary, Leeds; MRC Clinical Trials Unit; UCL Cancer Institute, University College, London; and Christie Hospital, University of Manchester, Withington, Manchester, Un

Clin Cancer Res ; 20(4): 1058, 2014 Feb 15.

Article em En | MEDLINE | ID: mdl-24536077

Assuntos

Inibidores da Angiogênese/uso terapêutico; Anticorpos Monoclonais Humanizados/uso terapêutico; Biomarcadores Tumorais/sangue; Neoplasias das Tubas Uterinas/sangue; Neoplasias Ovarianas/sangue; Seleção de Pacientes; Neoplasias Peritoneais/sangue; Feminino; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Biomarcadores Tumorais / Seleção de Pacientes / Inibidores da Angiogênese / Neoplasias das Tubas Uterinas / Anticorpos Monoclonais Humanizados Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google